Primary information |
---|
sequence ID | Seq_3903 |
Peptide sequence | ISASAEELRQR |
CancerPDF_ID | CancerPDF_ID368, CancerPDF_ID1374, CancerPDF_ID2577, |
PMID | 19795908,21136997,21136997 |
Protein Name | Apolipoprotein A-IV,Apolipoprotein A-IV,Apolipoprotein A-IV |
UniprotKB Entry Name | APOA4_HUMAN,APOA4_HUMAN,APOA4_HUMAN |
Fluid | Plasma,Serum,Plasma |
M/Z | 630.34,1258.66296,1258.663 |
Charge | 2,1,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS |
Labelled/Label Free | Labelled,Label Free,Label Free |
FDR | less than 7%,NA,0.001 |
CancerPDF_ID | CancerPDF_ID368, CancerPDF_ID1374, CancerPDF_ID2577, |
p-Value | NA,1.35E-05,4.20E-05 |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
Length | 11,11,11 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal |
Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "40 normal, 28 patients",30 patients and 30 healthy controls,27 healthy individuals |
Regulation | NA,Differentially expressed between cancer vs normal,Differentially expressed between cancer vs normal |
Validation | NA,Leave One out Cross validation,Leave One out Cross validation |
Sensitivity | NA,0.898,0.898 |
Specificity | NA,0.946,0.946 |
Accuracy | NA,NA,0.917 |
Peptide Atlas | PeptideAtlas |
IEDB | |